http://www.prnewswire.com/news-releases/bhr-pharma-announces-synapse-trial-completes-patient-enrollment-222156291.html
Fingers crossed. Sad to read that the other big ph3 trial with progesterone at EMORY (PROTECT III) was stopped in Nov 2013 for futility. http://www.nett.umich.edu/nett/files/minnesota_spoke_splash_nov_2013_no_contacts.pdf